Evercore ISI Remains Sidelined on Capital One Financial (COF) as Credit Concerns Likely Restrain Valuation
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Harry and Meghan surprised by King Charles' letter on their status
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Qualcomm to issue warrant to Amazon for up to 25M shares
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
After-Hours Stock Movers 01/26: (FATE) (RPTP) (ETH) Higher; (X) (LCI) (VMW) Lower (more...)
January 26, 2016 6:06 PM ESTCapnia, Inc. (NASDAQ: CAPN) 47.3% HIGHER; entered into an exclusive distribution agreement with Bemes, Inc., a leading medical equipment Master Distributor, to market and distribute the CoSense® End-Tidal Carbon Monoxide (ETCO) Monitor and Precision Sampling Sets (PSS).
Fate Therapeutics, Inc. (NASDAQ: FATE) 19.8% HIGHER; announced today the U.S. Food and Drug Administration (FDA) has cleared the Company's investigational new drug (IND) application for ProTmune, a programmed cellular immunotherapy consisting of donor-sourced mobilized peripheral blood cells which have been functionally... More
Capital One Financial (COF) Tops Q4 EPS by 6c
January 26, 2016 4:06 PM ESTCapital One Financial (NYSE: COF) reported Q4 EPS of $1.67, $0.06 better than the analyst estimate of $1.61.
For earnings history and earnings-related data on Capital One Financial (COF) click here.
... MoreTrading Radar for 1/26: Apple (AAPL), AT&T (T), J&J (JNJ), Procter & Gamble (PG), Capital One (COF) Report
January 25, 2016 2:14 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
9:00am EST
Earnings:
3M Co. (NYSE: MMM) - consensus EPS $1.63
AK Steel (NYSE: AKS) - consensus EPS $0.01
AVX Corp. (NYSE: AVX) - consensus EPS $0.17
Allegheny Technologies (NYSE: ATI) - consensus loss $0.48
Alliance... More
